STOCKHOLM, SE / ACCESS Newswire / August 19, 2025 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, ...

DEA Administrator Terrance Cole has also signaled a tough line: "Everybody knows my stance on marijuana after 30 plus years in law enforcement, so don't even ask!" However, with all due respect to law ...

Extrovis AG and Dr. Reddy’s announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S.                                      Extrovis AGBahnhof Park 46340, ...

ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM SystemTHIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE ...

Biocartis Welcomes Mike Kreitzinger as Senior Vice President of Global Business DevelopmentItasca (IL), United States, August 18th, 2025 – Biocartis Group of Companies (“Biocartis”), an innovative ...

Find the Role of OCP in Women’s HealthDid you know? Oral contraceptives have revolutionized women’s reproductive health by providing a safe and effective way to prevent unwanted pregnancies. However, ...

The global monoclonal antibody therapeutics market is set to witness a growth rate of ~12% in the next 5 years. Rising ...

The global IVD contract manufacturing services market is set to witness a growth rate of ~11% during the forecast ...

The global biologics consulting services market is set to witness a CAGR of ~15% in the next 5 years. Rising demand for ...

The global flow cytometry market is expected to witness a CAGR of ~9% during the forecast period. High incidence and ...

Faron Pharmaceuticals will publish its half-year financial results for January-June 2025 on Wednesday 27 August 2025 TURKU, FI / ACCESS Newswire / August 19, 2025 / Faron Pharmaceuticals Ltd.

CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LRSKAN Group reports ...